Tag: StockMarket

Browse our exclusive articles!

Profit from the Intelligence Age: Invest in AI Stocks

Investors, it's time to fall forward and consider emerging opportunities in AI stocks. As data-driven companies outperform non-data companies, AI technology is poised to change the world with AIaaS and facial recognition. Don't miss out on the biggest investment opportunity of your lifetime.

Goldman Sachs Shares 24 Stocks to Buy and Ride Higher with Market’s Year-End Rally

Looking to invest in the stock market? Goldman Sachs shares 24 stocks that it believes will rise higher after lagging behind during recent bull runs. Find out which companies made the list.

Goldman Sachs Identifies 9 Stocks Worth Buying Among 1,246 Hedge and Mutual Funds with $4.8 Trillion in Holdings

Find out which nine stocks hedge and mutual funds agree are worth buying, as analyzed by Goldman Sachs. Don't miss out on these top-performing investments.

Palantir: A Potentially Undervalued AI Stock (NYSE: PLTR)

Palantir Technologies Inc., a big data analytics company, has doubled its share price and boasts a market cap of $30 billion, making it a valuable investment opportunity. With robust revenue and FCF growth, it's capturing attention in the AI space and recently won a $463 million contract with US Special Forces. While continuing to grow its cash flow, Palantir's long-term sustainable growth prospects ensure its undervaluation. Explore why it's worth considering for your portfolio.

Asset Classes to Invest in for Maximum Gains in the New Market Shift

Schroders' Bob Armstrong advises investors to focus on fixed income, healthcare, and staples as the world shifts towards stickier inflation and a more hawkish monetary policy. He suggests small- and mid-cap stocks and commodities as strategic allocations that serve as an inflation hedge and portfolio diversifier.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img